MSD, Astellas Keep Fingers Crossed For EU Fast-Track Status
Executive Summary
The European Medicines Agency is this week considering applications from two companies seeking the coveted accelerated assessment review pathway for their new products.
You may also be interested in...
Daiichi Sankyo’s AML Drug Among Nine CHMP Hopefuls
Will regulators in the EU follow their US counterparts in requiring more efficacy data for Daiichi Sankyo’s acute myeloid leukemia drug quizartinib, which is already approved in Japan?
WHO To Facilitate Rapid Roll Out Of Merck's Ebola Vaccine In Africa
The World Health Organization is laying down the ground work to ensure that African countries at risk of an Ebola outbreak are able to approve the vaccine for use soon after it is authorized in the EU or the US.
EU Accelerated Assessment Tracker
Accelerated assessment requests at the European Medicines Agency.